Personalis (PSNL) Insider Trading & Ownership $5.40 -0.24 (-4.26%) (As of 11:03 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Personalis (NASDAQ:PSNL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$40,358.40 Get PSNL Insider Trade Alerts Want to know when executives and insiders are buying or selling Personalis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PSNL Insider Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Personalis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/30/2024Aaron TachibanaCFOSell742$2.97$2,203.74 7/30/2024Richard ChenEVPSell524$2.97$1,556.28 5/17/2024Aaron TachibanaCFOSell1,333$1.38$1,839.54 5/17/2024Richard ChenEVPSell940$1.38$1,297.20 5/17/2024Stephen Michael MooreSVPSell1,731$1.38$2,388.78 4/30/2024Stephen Michael MooreSVPSell4,523$1.37$6,196.51 NASDAQ small cap that could be gearing up for a massive short squeeze. (Ad)There is a NASDAQ Listed stock that has an INSANE Short position. It’s over 22 Million Shares short and the cost to borrow is over 140%!!! We are issuing an alert at the open tomorrow!!!Sign up now! To get this alert sent to you minutes before the open!1/29/2024Aaron TachibanaCFOSell716$1.37$980.92 1/29/2024Richard ChenEVPSell526$1.37$720.62 12/15/2023Aaron TachibanaCFOSell6,747$1.47$9,918.09 12/15/2023Richard ChenEVPSell4,708$1.47$6,920.76 12/15/2023Stephen Michael MooreGeneral CounselSell1,476$1.47$2,169.72 11/16/2023Aaron TachibanaCFOSell1,344$1.04$1,397.76 11/16/2023Richard ChenEVPSell940$1.04$977.60 11/16/2023Stephen Michael MooreGeneral CounselSell1,722$1.04$1,790.88 (Data available from 1/1/2013 forward) PSNL Insider Trading Activity - Frequently Asked Questions Who is on Personalis's Insider Roster? The list of insiders at Personalis includes Aaron Tachibana, Christopher M Hall, John Stephen West, Lightspeed Venture Partners Se, Richard Chen, and Stephen Michael Moore. Learn more on insiders at PSNL. What percentage of Personalis stock is owned by insiders? 4.10% of Personalis stock is owned by insiders. Learn more on PSNL's insider holdings. Which Personalis insiders have been selling company stock? The following insiders have sold PSNL shares in the last 24 months: Aaron Tachibana ($84,386.48), Christopher M Hall ($19,026.87), Richard Chen ($33,921.35), and Stephen Michael Moore ($35,704.48). How much insider selling is happening at Personalis? Insiders have sold a total of 98,139 Personalis shares in the last 24 months for a total of $173,039.18 sold. Personalis Key ExecutivesMr. Christopher M. Hall (Age 55)President, CEO & Director Compensation: $963.75kMr. Aaron L. Tachibana (Age 63)CFO & COO Compensation: $811k2 recent tradesMr. Stephen M. Moore J.D. (Age 52)Senior VP & Chief Legal Officer Compensation: $597.98kDr. Richard Chen M.D. (Age 53)M.S., Executive VP of R&D and Chief Medical Officer Compensation: $800.6kDr. Russ B. Altman M.D.Ph.D., Co-Founder and Member of Clinical & Scientific Advisory BoardDr. Euan A. Ashley DPHIL (Age 53)FRCP, M.D., Ph.D., Co-Founder and Member of Clinical & Scientific Advisory Board Dr. Michael P. Snyder Ph.D.Co-Founder and Member of Clinical & Scientific Advisory BoardMr. Michael J FitzpatrickVice President of Worldwide SalesDr. Christian Haudenschild Ph.D.Senior Vice President of Genomic Laboratory OperationsMr. Stephane Mouradian Ph.D.Senior Vice President of Business Development More Insider Trading Tools from MarketBeat Related Companies MacroGenics Insider Ownership agilon health Insider Ownership The Pennant Group Insider Ownership Aveanna Healthcare Insider Ownership Castle Biosciences Insider Ownership InnovAge Insider Ownership Fulgent Genetics Insider Ownership Celcuity Insider Ownership Sharecare Insider Ownership Grail Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors This page (NASDAQ:PSNL) was last updated on 11/6/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredStrange new catalyst for gold ($5,000 possible?)Gold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silve...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
